Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Pharmaceuticals and Biotechnology R&D market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Pharmaceuticals and Biotechnology R&D market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.
Segmented by Category
Drug
Medical Equipment
Vaccine
Others
Segmented by End User/Segment
Hospital
Clinic
Homecare
Others
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
TEVA PHARMACEUTICAL INDUSTRIES
TAKEDA PHARMACEUTICAL
SANOFI
ROCHE
PFIZER
NOVO NORDISK
NOVARTIS
MERCK
JOHNSON & JOHNSON
GLAXOSMITHKLINE
GILEAD SCIENCES
ELI LILLY
BRISTOL-MYERS SQUIBB
BOEHRINGER SOHN
BIOGEN
BAYER
ASTRAZENECA
ASTELLAS PHARMA
AMGEN
ABBVIE
ABBOTT
Table of Contents
1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Pharmaceuticals and Biotechnology R&D Market Status and Forecast (2016-2027)
1.3.2 Global Pharmaceuticals and Biotechnology R&D Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Pharmaceuticals and Biotechnology R&D Supply by Company
2.1 Global Pharmaceuticals and Biotechnology R&D Sales Value by Company
2.2 Pharmaceuticals and Biotechnology R&D Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Pharmaceuticals and Biotechnology R&D Market Status by Category
3.1 Pharmaceuticals and Biotechnology R&D Category Introduction
3.1.1 Drug
3.1.2 Medical Equipment
3.1.3 Vaccine
3.1.4 Others
3.2 Global Pharmaceuticals and Biotechnology R&D Market by Category
3.3 North America: by Category
3.4 Europe: by Category
3.5 Asia Pacific: by Category
3.6 Central & South America: by Category
3.7 Middle East & Africa: by Category
4 Global and Regional Pharmaceuticals and Biotechnology R&D Market Status by End User/Segment
4.1 Pharmaceuticals and Biotechnology R&D Segment by End User/Segment
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Homecare
4.1.4 Others
4.2 Global Pharmaceuticals and Biotechnology R&D Market by End User/Segment
4.3 North America: by End User/Segment
4.4 Europe: by End User/Segment
4.5 Asia Pacific: by End User/Segment
4.6 Central & South America: by End User/Segment
4.7 Middle East & Africa: by End User/Segment
5 Global Pharmaceuticals and Biotechnology R&D Market Status by Region
5.1 Global Pharmaceuticals and Biotechnology R&D Market by Region
5.2 North America Pharmaceuticals and Biotechnology R&D Market Status
5.3 Europe Pharmaceuticals and Biotechnology R&D Market Status
5.4 Asia Pacific Pharmaceuticals and Biotechnology R&D Market Status
5.5 Central & South America Pharmaceuticals and Biotechnology R&D Market Status
5.6 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Status
6 North America Pharmaceuticals and Biotechnology R&D Market Status
6.1 North America Pharmaceuticals and Biotechnology R&D Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Pharmaceuticals and Biotechnology R&D Market Status
7.1 Europe Pharmaceuticals and Biotechnology R&D Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Pharmaceuticals and Biotechnology R&D Market Status
8.1 Asia Pacific Pharmaceuticals and Biotechnology R&D Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Pharmaceuticals and Biotechnology R&D Market Status
9.1 Central & South America Pharmaceuticals and Biotechnology R&D Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Status
10.1 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Pharmaceuticals and Biotechnology R&D Market Forecast by Category and by End User/Segment
12.1 Global Pharmaceuticals and Biotechnology R&D Sales Value Forecast (2022-2027)
12.2 Global Pharmaceuticals and Biotechnology R&D Forecast by Category
12.3 Global Pharmaceuticals and Biotechnology R&D Forecast by End User/Segment
13 Global Pharmaceuticals and Biotechnology R&D Market Forecast by Region/Country
13.1 Global Pharmaceuticals and Biotechnology R&D Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 TEVA PHARMACEUTICAL INDUSTRIES
14.1.1 Company Information
14.1.2 Pharmaceuticals and Biotechnology R&D Product Introduction
14.1.3 TEVA PHARMACEUTICAL INDUSTRIES
Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 TAKEDA PHARMACEUTICAL
14.2.1 Company Information
14.2.2 Pharmaceuticals and Biotechnology R&D Product Introduction
14.2.3 TAKEDA PHARMACEUTICAL
Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 SANOFI
14.3.1 Company Information
14.3.2 Pharmaceuticals and Biotechnology R&D Product Introduction
14.3.3 SANOFI
Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 ROCHE
14.4.1 Company Information
14.4.2 Pharmaceuticals and Biotechnology R&D Product Introduction
14.4.3 ROCHE
Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 PFIZER
14.5.1 Company Information
14.5.2 Pharmaceuticals and Biotechnology R&D Product Introduction
14.5.3 PFIZER
Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 NOVO NORDISK
14.6.1 Company Information
14.6.2 Pharmaceuticals and Biotechnology R&D Product Introduction
14.6.3 NOVO NORDISK
Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 NOVARTIS
14.7.1 Company Information
14.7.2 Pharmaceuticals and Biotechnology R&D Product Introduction
14.7.3 NOVARTIS
Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 MERCK
14.8.1 Company Information
14.8.2 Pharmaceuticals and Biotechnology R&D Product Introduction
14.8.3 MERCK
Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
14.9 JOHNSON & JOHNSON
14.9.1 Company Information
14.9.2 Pharmaceuticals and Biotechnology R&D Product Introduction
14.9.3 JOHNSON & JOHNSON
Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
14.9.4 SWOT Analysis
14.10 GLAXOSMITHKLINE
14.10.1 Company Information
14.10.2 Pharmaceuticals and Biotechnology R&D Product Introduction
14.10.3 GLAXOSMITHKLINE
Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
14.10.4 SWOT Analysis
14.11 GILEAD SCIENCES
14.12 ELI LILLY
14.13 BRISTOL-MYERS SQUIBB
14.14 BOEHRINGER SOHN
14.15 BIOGEN
14.16 BAYER
14.17 ASTRAZENECA
14.18 ASTELLAS PHARMA
14.19 AMGEN
14.20 ABBVIE
14.21 ABBOTT
15 Conclusion
16 Methodology
List of Tables
Table Global Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Company (2019-2021)
Table Global Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Pharmaceuticals and Biotechnology R&D Sales Area
Table Pharmaceuticals and Biotechnology R&D Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Category (2016-2021)
Table Global Pharmaceuticals and Biotechnology R&D Sals Value Market Share by Category (2016-2021)
Table North America Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Category (2016-2021)
Table North America Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Category (2016-2021)
Table Europe Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Category (2016-2021)
Table Europe Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Category (2016-2021)
Table Asia Pacific Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Category (2016-2021)
Table Asia Pacific Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Category (2016-2021)
Table Central & South America Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Category (2016-2021)
Table Central & South America Pacific Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Category (2016-2021)
Table Middle East & Africa Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Category (2016-2021)
Table Middle East & Africa Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Category (2016-2021)
Table Global Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by End User/Segment (2016-2021)
Table Global Pharmaceuticals and Biotechnology R&D Value Market Share by End User/Segment (2016-2021)
Table North America Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by End User/Segment (2016-2021)
Table North America Pharmaceuticals and Biotechnology R&D Sales Value Market Share by End User/Segment (2016-2021)
Table Europe Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by End User/Segment (2016-2021)
Table Europe Pharmaceuticals and Biotechnology R&D Sales Value Market Share by End User/Segment (2016-2021)
Table Asia Pacific Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by End User/Segment (2016-2021)
Table Asia Pacific Pharmaceuticals and Biotechnology R&D Sales Value Market Share by End User/Segment (2016-2021)
Table Central & South America Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by End User/Segment (2016-2021)
Table Central & South America Pacific Pharmaceuticals and Biotechnology R&D Sales Value Market Share by End User/Segment (2016-2021)
Table Middle East & Africa Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by End User/Segment (2016-2021)
Table Middle East & Africa Pharmaceuticals and Biotechnology R&D Sales Value Market Share by End User/Segment (2016-2021)
Table Global Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Region (2016-2021)
Table Global Pharmaceuticals and Biotechnology R&D Value Market Share by Region (2016-2021)
Table North America Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Country (2016-2021)
Table North America Pharmaceuticals and Biotechnology R&D Value Market Share by Country (2016-2021)
Table Europe Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Country (2016-2021)
Table Europe Pharmaceuticals and Biotechnology R&D Value Market Share by Country (2016-2021)
Table Asia Pacific Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Pharmaceuticals and Biotechnology R&D Value Market Share by Country (2016-2021)
Table Central & South America Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Pharmaceuticals and Biotechnology R&D Value Market Share by Country (2016-2021)
Table Middle East & Africa Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Pharmaceuticals and Biotechnology R&D Value Market Share by Country (2016-2021)
Table Global Pharmaceuticals and Biotechnology R&D Value (Million USD) Forecast by Category (2022-2027)
Table Global Pharmaceuticals and Biotechnology R&D Value Market Share Forecast by Category (2022-2027)
Table Global Pharmaceuticals and Biotechnology R&D Value (Million USD) Forecast by End User/Segment (2022-2027)
Table Global Pharmaceuticals and Biotechnology R&D Value Market Share Forecast by End User/Segment (2022-2027)
Table Global Pharmaceuticals and Biotechnology R&D Value (Million USD) Forecast by Region (2022-2027)
Table Global Pharmaceuticals and Biotechnology R&D Value Market Share Forecast by Region (2022-2027)
Table TEVA PHARMACEUTICAL INDUSTRIES
Company Information
Table TEVA PHARMACEUTICAL INDUSTRIES
Product Introduction
Table TEVA PHARMACEUTICAL INDUSTRIES
Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
Table TAKEDA PHARMACEUTICAL
Company Information
Table TAKEDA PHARMACEUTICAL
Product Introduction
Table TAKEDA PHARMACEUTICAL
Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
Table SANOFI
Company Information
Table SANOFI
Product Introduction
Table SANOFI
Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
Table ROCHE
Company Information
Table ROCHE
Product Introduction
Table ROCHE
Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
Table PFIZER
Company Information
Table PFIZER
Product Introduction
Table PFIZER
Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
Table NOVO NORDISK
Company Information
Table NOVO NORDISK
Product Introduction
Table NOVO NORDISK
Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
Table NOVARTIS
Company Information
Table NOVARTIS
Product Introduction
Table NOVARTIS
Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
Table MERCK
Company Information
Table MERCK
Product Introduction
Table MERCK
Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
Table JOHNSON & JOHNSON
Company Information
Table JOHNSON & JOHNSON
Product Introduction
Table JOHNSON & JOHNSON
Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
Table GLAXOSMITHKLINE
Company Information
Table GLAXOSMITHKLINE
Product Introduction
Table GLAXOSMITHKLINE
Pharmaceuticals and Biotechnology R&D Sales Value, Gross Margin and Global Share (2019-2021)
List of Figures
Figure Pharmaceuticals and Biotechnology R&D Picture
Figure Global Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) and Growth Rate (2016-2027)
Figure Global Pharmaceuticals and Biotechnology R&D Sales Value CAGR (2020-2027) by Region
Figure Global Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Company, 2020
Figure Product Picture of Drug
Figure Product Picture of Medical Equipment
Figure Product Picture of Vaccine
Figure Product Picture of Others
Figure Global Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Category, 2020
Figure North America Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Category, 2020
Figure Europe Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Category, 2020
Figure Asia Pacific Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Category, 2020
Figure Central & South America Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Category, 2020
Figure Middle East & Africa Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Category, 2020
Figure Pharmaceuticals and Biotechnology R&D in Hospital
Figure Global Pharmaceuticals and Biotechnology R&D Market: Hospital
(2016-2021)
Figure Pharmaceuticals and Biotechnology R&D in Clinic
Figure Global Pharmaceuticals and Biotechnology R&D Market: Clinic
(2016-2021)
Figure Pharmaceuticals and Biotechnology R&D in Homecare
Figure Global Pharmaceuticals and Biotechnology R&D Market: Homecare
(2016-2021)
Figure Pharmaceuticals and Biotechnology R&D in Others
Figure Global Pharmaceuticals and Biotechnology R&D Market: Others (2016-2021)
Figure Global Pharmaceuticals and Biotechnology R&D Sales Value Market Share by End User/Segment, 2020
Figure North America Pharmaceuticals and Biotechnology R&D Sales Value Market Share by End User/Segment, 2020
Figure Europe Pharmaceuticals and Biotechnology R&D Sales Value Market Share by End User/Segment, 2020
Figure Asia Pacific Pharmaceuticals and Biotechnology R&D Sales Value Market Share by End User/Segment, 2020
Figure Central & South America Pharmaceuticals and Biotechnology R&D Sales Value Market Share by End User/Segment, 2020
Figure Middle East & Africa Pharmaceuticals and Biotechnology R&D Sales Value Market Share by End User/Segment, 2020
Figure Global Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Region (2016-2021)
Figure North America Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) Status (2016-2021)
Figure Europe Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) Status (2016-2021)
Figure Asia Pacific Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) Status (2016-2021)
Figure Central & South America Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) Status (2016-2021)
Figure Middle East & Africa Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) Status (2016-2021)
Figure North America Pharmaceuticals and Biotechnology R&D Sales Value Market Share by Country, 2020
Figure United States Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) Status (2016-2021)
Figure Canada Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) Status (2016-2021)
Figure Mexico Pharmaceuticals and Biotechnology R&D Sales Value (Million USD) Status (2016-2021)